Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study

Jennifer Glick, Tricia Christensen, Ju Nyeong Park, Michelle McKenzie, Traci C. Green, Susan Sherman

Research output: Contribution to journalArticle

Abstract

Background: The opioid epidemic is one of the greatest public health crises of our times, driven increasingly by synthetic opioids such as fentanyl in the heroin supply. The implementation of drug checking in community settings has the potential to reduce the burden of fatal overdose, provide harm reduction education around safer drug consumption, and increase health access among people who use drugs (PWUD). To inform program development, we explored stakeholder opinions on drug checking technologies and implementation considerations. Methods: This study, from the larger FORECAST study, utilized semi-structured in-depth interviews (n = 32) with a range of stakeholders in Baltimore, Boston, and Providence, many of whom were service providers. Stakeholders represented various roles and levels in organization types including harm reduction, public health, peer groups, and advocates. Interviews were audio recorded and transcribed. Data were coded using a priori codes; the coded text was analyzed for key themes. Results: Stakeholders responded positively to drug checking technology, though they shared apprehensions regarding service implementation. Primary topics requiring consideration included: utility in fentanyl endemic areas, trust and rapport between providers and PWUD, legality and policy concerns. Additional considerations included: technology accuracy, cost, ease of distribution, and service delivery setting. Conclusions: Stakeholders overwhelmingly supported the concept of drug checking with the goals of providing needed risk reduction information and resources to PWUD and serving as a point for greater engagement in services. Programs need to be tailored to local circumstances. Law enforcement buy-in and policy change will be critical aspects of providing drug checking services.

Original languageEnglish (US)
Pages (from-to)527-532
Number of pages6
JournalDrug and Alcohol Dependence
Volume194
DOIs
StatePublished - Jan 1 2019

Fingerprint

Fentanyl
Pharmaceutical Preparations
Harm Reduction
Public health
Technology
Opioid Analgesics
Public Health
Interviews
Peer Group
Law Enforcement
Baltimore
Program Development
Heroin
Law enforcement
Risk Reduction Behavior
Education
Health
Organizations
Costs and Cost Analysis

Keywords

  • Drug checking
  • Fentanyl
  • Implementation

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Stakeholder perspectives on implementing fentanyl drug checking : Results from a multi-site study. / Glick, Jennifer; Christensen, Tricia; Nyeong Park, Ju; McKenzie, Michelle; Green, Traci C.; Sherman, Susan.

In: Drug and Alcohol Dependence, Vol. 194, 01.01.2019, p. 527-532.

Research output: Contribution to journalArticle

Glick, Jennifer ; Christensen, Tricia ; Nyeong Park, Ju ; McKenzie, Michelle ; Green, Traci C. ; Sherman, Susan. / Stakeholder perspectives on implementing fentanyl drug checking : Results from a multi-site study. In: Drug and Alcohol Dependence. 2019 ; Vol. 194. pp. 527-532.
@article{3db0ad88f8f54578a87e6c8bc0d76913,
title = "Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study",
abstract = "Background: The opioid epidemic is one of the greatest public health crises of our times, driven increasingly by synthetic opioids such as fentanyl in the heroin supply. The implementation of drug checking in community settings has the potential to reduce the burden of fatal overdose, provide harm reduction education around safer drug consumption, and increase health access among people who use drugs (PWUD). To inform program development, we explored stakeholder opinions on drug checking technologies and implementation considerations. Methods: This study, from the larger FORECAST study, utilized semi-structured in-depth interviews (n = 32) with a range of stakeholders in Baltimore, Boston, and Providence, many of whom were service providers. Stakeholders represented various roles and levels in organization types including harm reduction, public health, peer groups, and advocates. Interviews were audio recorded and transcribed. Data were coded using a priori codes; the coded text was analyzed for key themes. Results: Stakeholders responded positively to drug checking technology, though they shared apprehensions regarding service implementation. Primary topics requiring consideration included: utility in fentanyl endemic areas, trust and rapport between providers and PWUD, legality and policy concerns. Additional considerations included: technology accuracy, cost, ease of distribution, and service delivery setting. Conclusions: Stakeholders overwhelmingly supported the concept of drug checking with the goals of providing needed risk reduction information and resources to PWUD and serving as a point for greater engagement in services. Programs need to be tailored to local circumstances. Law enforcement buy-in and policy change will be critical aspects of providing drug checking services.",
keywords = "Drug checking, Fentanyl, Implementation",
author = "Jennifer Glick and Tricia Christensen and {Nyeong Park}, Ju and Michelle McKenzie and Green, {Traci C.} and Susan Sherman",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.drugalcdep.2018.10.017",
language = "English (US)",
volume = "194",
pages = "527--532",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Stakeholder perspectives on implementing fentanyl drug checking

T2 - Results from a multi-site study

AU - Glick, Jennifer

AU - Christensen, Tricia

AU - Nyeong Park, Ju

AU - McKenzie, Michelle

AU - Green, Traci C.

AU - Sherman, Susan

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: The opioid epidemic is one of the greatest public health crises of our times, driven increasingly by synthetic opioids such as fentanyl in the heroin supply. The implementation of drug checking in community settings has the potential to reduce the burden of fatal overdose, provide harm reduction education around safer drug consumption, and increase health access among people who use drugs (PWUD). To inform program development, we explored stakeholder opinions on drug checking technologies and implementation considerations. Methods: This study, from the larger FORECAST study, utilized semi-structured in-depth interviews (n = 32) with a range of stakeholders in Baltimore, Boston, and Providence, many of whom were service providers. Stakeholders represented various roles and levels in organization types including harm reduction, public health, peer groups, and advocates. Interviews were audio recorded and transcribed. Data were coded using a priori codes; the coded text was analyzed for key themes. Results: Stakeholders responded positively to drug checking technology, though they shared apprehensions regarding service implementation. Primary topics requiring consideration included: utility in fentanyl endemic areas, trust and rapport between providers and PWUD, legality and policy concerns. Additional considerations included: technology accuracy, cost, ease of distribution, and service delivery setting. Conclusions: Stakeholders overwhelmingly supported the concept of drug checking with the goals of providing needed risk reduction information and resources to PWUD and serving as a point for greater engagement in services. Programs need to be tailored to local circumstances. Law enforcement buy-in and policy change will be critical aspects of providing drug checking services.

AB - Background: The opioid epidemic is one of the greatest public health crises of our times, driven increasingly by synthetic opioids such as fentanyl in the heroin supply. The implementation of drug checking in community settings has the potential to reduce the burden of fatal overdose, provide harm reduction education around safer drug consumption, and increase health access among people who use drugs (PWUD). To inform program development, we explored stakeholder opinions on drug checking technologies and implementation considerations. Methods: This study, from the larger FORECAST study, utilized semi-structured in-depth interviews (n = 32) with a range of stakeholders in Baltimore, Boston, and Providence, many of whom were service providers. Stakeholders represented various roles and levels in organization types including harm reduction, public health, peer groups, and advocates. Interviews were audio recorded and transcribed. Data were coded using a priori codes; the coded text was analyzed for key themes. Results: Stakeholders responded positively to drug checking technology, though they shared apprehensions regarding service implementation. Primary topics requiring consideration included: utility in fentanyl endemic areas, trust and rapport between providers and PWUD, legality and policy concerns. Additional considerations included: technology accuracy, cost, ease of distribution, and service delivery setting. Conclusions: Stakeholders overwhelmingly supported the concept of drug checking with the goals of providing needed risk reduction information and resources to PWUD and serving as a point for greater engagement in services. Programs need to be tailored to local circumstances. Law enforcement buy-in and policy change will be critical aspects of providing drug checking services.

KW - Drug checking

KW - Fentanyl

KW - Implementation

UR - http://www.scopus.com/inward/record.url?scp=85058097611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058097611&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2018.10.017

DO - 10.1016/j.drugalcdep.2018.10.017

M3 - Article

C2 - 30551090

AN - SCOPUS:85058097611

VL - 194

SP - 527

EP - 532

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

ER -